Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.45% |
$931
$1.38 p/Share
|
Oct 19
2020 |
STT
|
Francisco Aristeguieta
EVP and CEO of Inst. Services |
SELL
Open market or private sale
|
Direct | 62,183 Reduced 39.75% |
$4,123,355
$66.31 p/Share
|
Oct 19
2020 |
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 14 Added 0.01% |
$6,608
$472.0 p/Share
|
Oct 19
2020 |
FDX
|
John L Merino
CVP PRIN ACCT OFFICER |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 15.5% |
$1,446,550
$289.31 p/Share
|
Oct 19
2020 |
ACN
|
Johan Deblaere
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 4.79% |
$689,490
$229.83 p/Share
|
Oct 19
2020 |
ACN
|
James O Etheredge
Chief Exec-North America |
SELL
Open market or private sale
|
Direct | 1,670 Reduced 10.48% |
$381,845
$228.65 p/Share
|
Oct 19
2020 |
ACN
|
Kathleen R Mc Clure
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,250 Reduced 11.02% |
$518,467
$230.43 p/Share
|
Oct 19
2020 |
ACN
|
Jean Marc Ollagnier
CEO EMEA |
SELL
Open market or private sale
|
Direct | 3,684 Reduced 2.01% |
$846,988
$229.91 p/Share
|
Oct 19
2020 |
ACN
|
David Rowland
Executive Chairman |
SELL
Open market or private sale
|
Direct | 10,938 Reduced 42.04% |
$2,500,864
$228.64 p/Share
|
Oct 19
2020 |
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$1,087,800
$72.52 p/Share
|
Oct 19
2020 |
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,000 Added 50.0% |
$235,200
$15.68 p/Share
|
Oct 19
2020 |
UPWK
|
Hayden Brown
President & CEO |
SELL
Open market or private sale
|
Direct | 1,314 Reduced 0.32% |
$27,134
$20.65 p/Share
|
Oct 19
2020 |
JBL
|
Steven D Borges
EVP, Global Business Units |
SELL
Payment of exercise price or tax liability
|
Direct | 1,154 Reduced 0.36% |
$41,902
$36.31 p/Share
|
Oct 19
2020 |
JBL
|
Sergio Cadavid
SVP, Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 542 Reduced 0.79% |
$19,680
$36.31 p/Share
|
Oct 19
2020 |
JBL
|
Bruce Allan Johnson
EVP, Chief Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct | 1,277 Reduced 0.57% |
$46,368
$36.31 p/Share
|
Oct 19
2020 |
JBL
|
Robert L Katz
EVP, CLO & Asst Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 1,592 Reduced 0.75% |
$57,806
$36.31 p/Share
|
Oct 19
2020 |
JBL
|
Michael J Loparco
EVP, CEO, EMS |
SELL
Payment of exercise price or tax liability
|
Direct | 1,597 Reduced 0.46% |
$57,987
$36.31 p/Share
|
Oct 19
2020 |
JBL
|
Mark T Mondello
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 13,951 Reduced 0.61% |
$506,561
$36.31 p/Share
|
Oct 19
2020 |
JBL
|
Daryn G. Smith
SVP, Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 560 Reduced 0.29% |
$20,334
$36.31 p/Share
|
Oct 19
2020 |
JBL
|
Kenneth S Wilson
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,720 Reduced 0.63% |
$62,453
$36.31 p/Share
|
Oct 19
2020 |
EMKR
|
Jeffrey Rittichier
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 9,038 Reduced 3.38% |
$30,277
$3.35 p/Share
|
Oct 19
2020 |
MSM
|
Steve Armstrong
SVP, GC and Corp. Secy. |
SELL
Payment of exercise price or tax liability
|
Direct | 317 Reduced 2.94% |
$20,865
$65.82 p/Share
|
Oct 19
2020 |
MSM
|
Steve Armstrong
SVP, GC and Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct | 933 Added 7.97% |
-
|
Oct 19
2020 |
MSM
|
Steven N Baruch
EVP, STRATEGY & MARKETING |
SELL
Payment of exercise price or tax liability
|
Direct | 137 Reduced 1.58% |
$9,017
$65.82 p/Share
|
Oct 19
2020 |
MSM
|
Steven N Baruch
EVP, STRATEGY & MARKETING |
BUY
Exercise of conversion of derivative security
|
Direct | 463 Added 5.08% |
-
|
Oct 19
2020 |
MSM
|
Charles Bonomo
Senior VP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct | 276 Reduced 4.89% |
$18,166
$65.82 p/Share
|
Oct 19
2020 |
MSM
|
Charles Bonomo
Senior VP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct | 811 Added 12.57% |
-
|
Oct 19
2020 |
MSM
|
Kari D Heerdt
SVP, New Business Innovation |
SELL
Payment of exercise price or tax liability
|
Direct | 241 Reduced 2.39% |
$15,863
$65.82 p/Share
|
Oct 19
2020 |
MSM
|
Kari D Heerdt
SVP, New Business Innovation |
BUY
Exercise of conversion of derivative security
|
Direct | 811 Added 7.45% |
-
|
Oct 19
2020 |
MSM
|
Douglas E Jones
EVP, Chief Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct | 378 Reduced 4.43% |
$24,880
$65.82 p/Share
|
Oct 19
2020 |
MSM
|
Douglas E Jones
EVP, Chief Supply Chain |
BUY
Exercise of conversion of derivative security
|
Direct | 1,273 Added 12.99% |
-
|
Oct 19
2020 |
MSM
|
Gregory Polli
SVP, PRODUCT MANAGEMENT |
SELL
Payment of exercise price or tax liability
|
Direct | 208 Reduced 2.63% |
$13,691
$65.82 p/Share
|
Oct 19
2020 |
MSM
|
Gregory Polli
SVP, PRODUCT MANAGEMENT |
BUY
Exercise of conversion of derivative security
|
Direct | 613 Added 7.19% |
-
|
Oct 19
2020 |
MSM
|
Erik Gershwind
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 0 Reduced 0.0% |
$0
$65.82 p/Share
|
Oct 19
2020 |
MSM
|
Erik Gershwind
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,475 Added 1.29% |
-
|
Oct 19
2020 |
KOR
|
Ed Yarrow |
BUY
Exercise of conversion of derivative security
|
Direct | 100,000 Added 19.05% |
$106,000
$1.06 p/Share
|
Oct 19
2020 |
LOVE
|
Andrew R Heyer
Director |
SELL
Open market or private sale
|
Indirect | 24,151 Reduced 0.37% |
$841,179
$34.83 p/Share
|
Oct 19
2020 |
GNLN
|
Aaron Lo Cascio
Director |
SELL
Open market or private sale
|
Direct | 20,021 Reduced 15.81% |
$56,059
$2.8 p/Share
|
Oct 19
2020 |
SELB
|
Timothy A Springer
Director |
BUY
Open market or private purchase
|
Indirect | 759,500 Added 7.11% |
$1,792,420
$2.36 p/Share
|
Oct 19
2020 |
PRTS
|
Joshua L Berman
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 16.74% |
$253,000
$12.65 p/Share
|
Oct 19
2020 |
PRTS
|
Joshua L Berman
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 14.34% |
$46,600
$2.33 p/Share
|
Oct 19
2020 |
SIBN
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct | 8,274 Reduced 3.61% |
$211,732
$25.59 p/Share
|
Oct 19
2020 |
UPLD
|
Timothy Mattox
Director |
SELL
Open market or private sale
|
Direct | 29,713 Reduced 5.75% |
$1,337,085
$45.0 p/Share
|
Oct 19
2020 |
STOK
|
Gene Liau
EVP Research & Preclinical Dev |
SELL
Open market or private sale
|
Direct | 32,000 Reduced 70.33% |
$1,216,960
$38.03 p/Share
|
Oct 19
2020 |
STOK
|
Gene Liau
EVP Research & Preclinical Dev |
BUY
Exercise of conversion of derivative security
|
Direct | 32,000 Added 41.29% |
$44,800
$1.4 p/Share
|
Oct 19
2020 |
FLWS
|
Christopher G Mccann
Director |
SELL
Open market or private sale
|
Direct | 17,850 Reduced 1.6% |
$514,973
$28.85 p/Share
|
Oct 19
2020 |
FLWS
|
Christopher G Mccann
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 17,850 Added 1.57% |
$46,946
$2.63 p/Share
|
Oct 19
2020 |
XPEL
|
Mark Adams
Director |
SELL
Open market or private sale
|
Direct | 6,502 Reduced 0.22% |
$175,034
$26.92 p/Share
|
Oct 19
2020 |
EAF
|
Bcp Gp LTD |
SELL
Open market or private sale
|
Indirect | 106,973 Reduced 0.02% |
$754,160
$7.05 p/Share
|
Oct 19
2020 |
EAF
|
Bcp Gp LTD |
SELL
Open market or private sale
|
Indirect | 106,973 Reduced 0.02% |
$754,160
$7.05 p/Share
|
Oct 19
2020 |